The COVID-19 outbreak boosted the sterile tube welder market by increasing the use of sterilized hospital supplies and devices to avoid coronavirus contamination. Blood testing also aids in the diagnosis of infectious diseases such as COVID-19.
The North American region was expected to hold a significant revenue share of the global sterile tube welder market in 2021. A rise in the incidence of chronic diseases, recent advancements in technology, and a high demand for sterile and hygienic environments to prevent contamination are key factors driving market expansion in the region. One of the primary drivers of regional market growth is the rising burden of chronic disorders in the United States. The National Health Council's 2020 report estimates that at least 157 million North American people have at minimum one chronic condition. It is also estimated that chronic illnesses cause 7 out of every ten deaths, with chronic kidney disease being one of the major causes in the United States.
The United States led the North American sterile tube welder market in 2021 due to rising demand for a hygienic environment, chronic disease prevalence, technological advancements, favorable reimbursement policies, and well-established healthcare infrastructure. According to the American Red Cross's 2021 updated estimates, roughly 36,000 units of red blood cells are required daily, and nearly 21 million blood products are transfused annually. Such a high demand for blood products is anticipated to drive demand for infrastructure related to sterile processing, blood processing, and infrastructure facilities, supporting the market growth for sterile tubing welders. The growing need for reliable diagnostic tools to get the right treatment for chronic conditions is also anticipated to fuel market expansion in the United States.
The sterile tube welder market is highly fragmented, with many mid-sized players. Nevertheless, the market has seen many such deals owing to ongoing efforts by leading market players to pursue mergers and acquisitions as a crucial strategic move. For instance, Sartorius completed its acquisition of Albumedix through its French-listed subcategory Sartorius Stedim Biotech in September 2022. Likewise, CPC (Colder Products Company), a Dover-based operating company, announced the launch of a new series of ultra-compact sterile tube connectors, the MicroCNX Series Connectors, in September 2021.
REPORT ATTRIBUTE | DETAILS |
---|---|
Sterile Tube Welder Market by Volume |
Yes |
Market by Value |
Yes |
Market, Tornado Analysis |
Yes |
Market, STAR Analysis |
Yes |
Market, SRC Analysis |
Yes |
Market, Import-Export Data |
Yes (On Demand) |
Market Pricing Analysis |
Yes (On Demand) |
Market Segment Analysis |
By Type (Manual and Automatic) By Application (Biopharmaceutical, Blood Processing, Diagnostic Laboratories, and Others) By End-Use (Hospitals, Research Clinics, Blood Centers, and Others) |
Market, Regional Analysis |
North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and the Rest of the Middle East and Africa) |
Market Key Companies |
Sartorius Stedim Biotech S.A., Terumo BCT Inc, GE Healthcare, MGA Technologies, VANTE Biopharm, Genesis BPS, Biomen Biosystems Company Ltd, Flex Concepts Inc, and Shanghai Le Pure Biological Technology Co. Ltd |
Market Competitive Landscape |
Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted |
The use of larger-diameter pipes in biotech applications necessitates the use of sterile welding equipment. Samples are transferred or put right into a sterile tube, which needs to be sealed tightly and taken to the lab for analysis. The welders can also be used in blood banks for blood bag-type tubing or applications related to blood centers. The extraction procedure and donor safety have been enhanced by the creation of techniques to isolate specialized blood cells, such as Hematopoietic Progenitor Cells (HPC), which has increased demand for HPC transplantation and, in turn, boosted market demand for blood processing and sterile tube processing technologies.
Growing global demand for blood and blood-based products, rising R&D investments, and increased use of single-use technologies are a few factors driving the growth of sterile tube welders over the forthcoming years. Major market players focus on growing their product offerings and global reach while attracting investments through strategic alliances, mergers, and acquisitions. For instance, Terumo BCT Inc acquired certain assets from Abbott and St. Jude and a vascular closure company in 2017. Similarly, Machine Solutions Inc, the parent company of Vante Inc, declared in April 2018 that it had purchased SEBRA, the industry's top supplier of tube sealing machinery.
Some major players in the sterile tube welder market are Sartorius Stedim Biotech S.A., Terumo BCT Inc, GE Healthcare, MGA Technologies, VANTE Biopharm, Genesis BPS, Biomen Biosystems Company Ltd, Flex Concepts Inc, Shanghai Le Pure Biological Technology Co. Ltd.
Key factors anticipated to drive the growth of the sterile tube welder market include the rapidly rising demand for personalized medicines, rising healthcare costs, and growing concern over the rising prevalence of chronic diseases. Increased blood transfusions led to a high demand for and widespread use of blood products, which fueled the market expansion. Additionally, contaminated blood results in waste, bad storage, and improper handling of the blood processing process. These factors also boost interest in automated sterile tubing welders, further expanding the global market.
The availability of alternatives for sterile tubing welders is expected to limit market expansion over the projected period. Besides, government standards for manufacturing sterile tubing welders are extremely stringent. The ISO standards for blood bags need to sufficiently define and regulate the diameters of transfer tubes for blood bags. The lack of uniformity may make it challenging to connect the many different tubes that have evolved in the absence of governmental standards.
The automatic mode segment is expected to hold a significant revenue share of the global sterile tube welder market throughout the projection period due to its portability and ease of use. End-users are in high demand for an inventive yet affordable solutions, like automated sterile tubing welders, to prevent the wastage of collected blood owing to contamination, inadequate storage, blood bag spillages, and a lack of proper processing facilities and skilled personnel. The automatic sterile tubing welder is a machine that joins plastic or metal tubes used in medicine by applying pressure and heat. This apparatus does not require an external energy source since sealing occurs due to the high temperature created when a hot die is pressed against a cold one. Additionally, it assists in creating tightly sealed, crimped joints that prevent leakage during transportation.
Asia Pacific market is anticipated to hold the largest revenue share in the global sterile tube welder market during the forecast period. Increased investment in R&D by major multinational corporations in this region has emerged as a key factor driving the expansion of the pharmaceutical and biopharmaceutical industries. Moreover, the growing geriatric population and a sizable middle-income population increase the demand for innovative and cost-effective sterile tubing welder devices to attract key medical device companies in the region. The rapidly growing pharmaceutical and biotechnology sectors in China will have a significant positive impact on the regional market for sterile tubing welders.
The government has extremely strict standards for the manufacture of sterile tubing welders. The diameters of the transfer tubes for blood bags need to be adequately defined and regulated by the ISO standards for blood bags. The numerous tubes that have developed in the absence of government standards may be difficult to connect due to the lack of uniformity.
The global sterile tube welder market is anticipated to grow at a substantial CAGR of 5.5% in the upcoming years. The global Sterile Tube Welder industry was estimated to be worth USD 2.1 billion in 2021 and was expected to be worth USD 2.89 billion by 2028.
Global sterile tube weld market players are expanding their product and business portfolios to meet the increasing demand for sterile tubing welders from customers in the biotechnology and pharmaceutical sectors. Customers are now able to choose the necessary product and any related solutions. A growing number of research projects to create new techniques for diagnosis and treatment and advanced technologies in sterile packaging and production are also anticipated to propel the growth of the sterile tube welder market in the upcoming years.
Global Sterile Tube Welder Market – By Mode
Global Sterile Tube Welder Market – By Application
Global Sterile Tube Welder Market – By End-Use
Global Sterile Tube Welder Market – By Region
The COVID-19 outbreak boosted the sterile tube welder market by increasing the use of sterilized hospital supplies and devices to avoid coronavirus contamination. Blood testing also aids in the diagnosis of infectious diseases such as COVID-19.
North America held the largest share of the global sterile tube welder market in 2021.
Some major factors expected to drive the sterile tube welder market growth are the increasing number of blood transfusions globally, rising demand for personalized medicines, rising healthcare expenditure, and growing concern about the rising prevalence of chronic diseases.
The automatic segment had a major share in the global market in 2021.
In 2021, the blood processing segment had a major share in the global market.
Report Attribute | Details |
---|---|
Market Value in 2021 | USD 2.1 billion |
Market Value in 2028 | USD 2.89 billion |
CAGR | 5.5% |
Benchmarking Year | 2021 |
Past data | 2016 – 2021 |
Forecast period | 2022 – 2028 |